Explosive Hazard Identification in Pharmaceutical Process Development

London, UK: Scitegrity, a leading company in chemical regulatory compliance, is excited to announce the expanded release of its Dangerous Goods Assessor for Pharmaceutical Process Development and safety teams.

This innovative web-based system has the capability to predict whether a chemical is likely to be energetic, self-reactive, or explosive during synthesis and scale-up processes.

As pharmaceutical process development often involves scaling up chemicals from milligram to gram levels, there is a significant need to assess the risks associated with explosion, self-reactivity, and energetic properties. Dangerous Goods Assessor addresses this challenge by providing a simple and efficient tool for process safety labs to screen for potential hazards, even when limited or no material is available for testing.

Scitegrity CEO, Joe Bradley, expressed his excitement about working closely with process safety experts and Dangerous Goods Safety Advisors (DGSAs) from major pharmaceutical companies to develop this tool. Having incorporated best practices and industry learnings, Scitegrity is now proud to introduce DG Assessor to the wider industry.

About Scitegrity

Since its establishment in 2011, Scitegrity has been committed to enhancing compliance with chemical regulations through robust, accurate, and automated solutions. Today, their solutions are trusted by over half of the world's top 10 pharmaceutical companies, as well as chemical suppliers, CROs, and regulators.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scitegrity. (2024, February 13). Explosive Hazard Identification in Pharmaceutical Process Development. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20230901/Explosive-Hazard-Identification-in-Pharmaceutical-Process-Development.aspx.

  • MLA

    Scitegrity. "Explosive Hazard Identification in Pharmaceutical Process Development". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20230901/Explosive-Hazard-Identification-in-Pharmaceutical-Process-Development.aspx>.

  • Chicago

    Scitegrity. "Explosive Hazard Identification in Pharmaceutical Process Development". News-Medical. https://www.news-medical.net/news/20230901/Explosive-Hazard-Identification-in-Pharmaceutical-Process-Development.aspx. (accessed November 21, 2024).

  • Harvard

    Scitegrity. 2024. Explosive Hazard Identification in Pharmaceutical Process Development. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20230901/Explosive-Hazard-Identification-in-Pharmaceutical-Process-Development.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.